Labetolol HCL Tablets
Award Notice Posted
- Solicitation number
- 36E79718R0011
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Awarded
- to Sandoz Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 36E79718C0016 Federal IDV award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- Not on record
Notice details come from SAM.gov. Updated .
Notice text
Added: Nov 16, 2017 2:56 pm
Page 1 of 1
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79718R0011 for an unrestricted procurement for Labetalol Tablets, for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). Award will be made to the responsible contractor(s) per individual product group or a combination of product groups if this results in the lowest overall price to the Government. To be considered for award, offerors must propose prices for all line items for the base and each option year for all items within a product group or groups proposed. Line items 1, 2, 3, 4, and 5. The period of contract will be for one year plus four one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Solicitation # 36E79718R0011 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about December 4, 2017, with a tentative closing date of December 19, 2017. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.fedbizopps.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted.  Interested offerors are advised to continuously check this URL for any changes to this solicitation. Offers will be considered technically acceptable if the meet the following criteria: 1) NDC must be unique to the offeror, 2) Drug must be FDA approved, 3) Manufacturing facility must have an acceptable current Good Manufacturing Practices rating by FDA. 4) Offeror must meet the estimated annual requirements as listed below. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Richard Mahario. Questions can be e-mailed to: Richard.Mahario@va.gov Â
The estimated annual requirements are as follows:
Description      Size  Estimated Annual Requirements
Labetalol HCL 100MG Bottles of 100 Tablets 26,864
Labetalol HCL 100MG Bottles of 500 Tablets 2,785
Labetalol HCL 200MG Bottles of 100 Tablets 19,889
Labetalol HCL 200MG Bottles of 500 Tablets 9,681
Labetalol HCL 300MG Bottles of 100 Tablets 20,544
Files
| File | Type | Posted |
|---|---|---|
| 36E79718C0016-000.docx | DOCX document | |
| 36E79718R0011-001.docx | DOCX document | |
| 36E79718R0011-000.docx | DOCX document |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity